Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giby V George

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Ejhaem|June 19, 2024
Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?Giby V George, Diana G Aldowitz, Audrey N Jajosky, et al.
Cancers|January 8, 2023
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine LeiomyosarcomaMaggie Zhou, Nam Bui, Richa Rathore, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2024
Cyclin-D1 rearrangement as a secondary event in the large cell transformation of splenic marginal zone lymphoma with a TP53 deletionGiby V George, Diana G Adlowitz, K Riley Okeson, et al.
Frontiers in Oncology|August 13, 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphomaMayur Narkhede, Sarah Tomassetti, Madiha Iqbal, et al.
JCO Precision Oncology|May 5, 2025
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the BreastJulia Foldi, Steffi Oesterreich, Antony Tin, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
JCO Precision Oncology|December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Scientific Reports|November 28, 2024
Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapyChiara Molinari, Giorgia Marisi, George Laliotis, et al.
Annals of Surgery|March 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational StudyShogo Takei, Daisuke Kotani, George Laliotis, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Ejhaem|June 19, 2024
Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?Giby V George, Diana G Aldowitz, Audrey N Jajosky, et al.
Cancers|January 8, 2023
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine LeiomyosarcomaMaggie Zhou, Nam Bui, Richa Rathore, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2024
Cyclin-D1 rearrangement as a secondary event in the large cell transformation of splenic marginal zone lymphoma with a TP53 deletionGiby V George, Diana G Adlowitz, K Riley Okeson, et al.
Frontiers in Oncology|August 13, 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphomaMayur Narkhede, Sarah Tomassetti, Madiha Iqbal, et al.
JCO Precision Oncology|May 5, 2025
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the BreastJulia Foldi, Steffi Oesterreich, Antony Tin, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
JCO Precision Oncology|December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Scientific Reports|November 28, 2024
Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapyChiara Molinari, Giorgia Marisi, George Laliotis, et al.
Annals of Surgery|March 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational StudyShogo Takei, Daisuke Kotani, George Laliotis, et al.
Pageof 3